首页> 外文期刊>Bioconjugate Chemistry >Triaging of DNA-Encoded Library Selection Results by High-Throughput Resynthesis of DNA-Conjugate and Affinity Selection Mass Spectrometry
【24h】

Triaging of DNA-Encoded Library Selection Results by High-Throughput Resynthesis of DNA-Conjugate and Affinity Selection Mass Spectrometry

机译:DNA编码的图书馆选择的三环通过DNA缀合物和亲和选择质谱法的高通量再生合成

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

DNA encoded library (DEL) technology allows for rapid identification of novel small-molecule ligands and thus enables early-stage drug discovery. DEL technology is well-established, numerous cases of discovered hit molecules have been published, and the technology is widely employed throughout the pharmaceutical industry. Nonetheless, DEL selection results can be difficult to interpret, as library member enrichment may derive from not only desired products, but also DNA-conjugated byproducts and starting materials. Note that DELs are generally produced using split-and-pool combinatorial chemistry, and DNA-conjugated byproducts and starting materials cannot be removed from the library mixture. Herein, we describe a method for high-throughput parallel resynthesis of DNA-conjugated molecules such that byproducts, starting materials, and desired products are produced in a single pot, using the same chemical reactions and reagents as during library production. The low-complexity mixtures of DNA-conjugate are then assessed for protein binding by affinity selection mass spectrometry and the molecular weights of the binding ligands ascertained. This workflow is demonstrated to be a practical tool to triage and validate potential hits from DEL selection data.
机译:DNA编码库(Del)技术允许快速鉴定新型小分子配体,从而实现早期药物发现。 DEL技术已经完善,已发表了许多发现的命中分子的案例,该技术在整个制药行业中广泛使用。尽管如此,由于图书馆成员富集可能来自所需产品,而且难以解释,难以解释,而且还源于所需的产品,还可以衍生出DNA缀合的副产品和起始材料。注意,DEL通常使用分层和池组合化学生产,并且不能从文库混合物中除去DNA缀合的副产物和起始材料。在此,我们描述了一种用于DNA - 缀合分子的高通量并联再合成的方法,使得使用相同的化学反应和试剂在图书馆生产期间,使用相同的化学反应和试剂在单个罐中生产副产物,起始材料和所需产物。然后通过亲和选择质谱法评估DNA缀合物的低复杂性混合物对蛋白质结合,并确定结合配体的分子量。将此工作流程被证明是从DEL选择数据进行分类的实用工具和验证潜在命中。

著录项

  • 来源
    《Bioconjugate Chemistry》 |2021年第5期|共7页
  • 作者单位

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

    WuXi AppTec Shanghai Co Ltd Shanghai 200131 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号